Comprehensive molecular portraits of human breast tumours Brigham & Women’s Hospital & Harvard Medical School Chin Lynda 9 11 Park ... Nature 490 (7418), 61-70, 2012 | 11128 | 2012 |
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1 DJ Klionsky, AK Abdel-Aziz, S Abdelfatah, M Abdellatif, A Abdoli, S Abel, ... autophagy 17 (1), 1-382, 2021 | 10807 | 2021 |
Integrated genomic analyses of ovarian carcinoma Cancer Genome Atlas Research Network Nature 474 (7353), 609, 2011 | 6891 | 2011 |
The cancer genome atlas pan-cancer analysis project JN Weinstein, EA Collisson, GB Mills, KR Shaw, BA Ozenberger, K Ellrott, ... Nature genetics 45 (10), 1113-1120, 2013 | 6557 | 2013 |
Inferring tumour purity and stromal and immune cell admixture from expression data K Yoshihara, M Shahmoradgoli, E Martínez, R Vegesna, H Kim, ... Nature communications 4 (1), 2612, 2013 | 6390 | 2013 |
Comprehensive molecular characterization of gastric adenocarcinoma Cancer Genome Atlas Research Network Nature 513 (7517), 202, 2014 | 5177 | 2014 |
The somatic genomic landscape of glioblastoma CW Brennan, RGW Verhaak, A McKenna, B Campos, H Noushmehr, ... cell 155 (2), 462-477, 2013 | 4987 | 2013 |
Integrated genomic characterization of endometrial carcinoma DA Levine, ... Nature 497 (7447), 67-73, 2013 | 4900 | 2013 |
The immune landscape of cancer V Thorsson, DL Gibbs, SD Brown, D Wolf, DS Bortone, THO Yang, ... Immunity 48 (4), 812-830. e14, 2018 | 4483 | 2018 |
Use of proteomic patterns in serum to identify ovarian cancer EF Petricoin, AM Ardekani, BA Hitt, PJ Levine, VA Fusaro, SM Steinberg, ... The lancet 359 (9306), 572-577, 2002 | 4459 | 2002 |
Comprehensive molecular characterization of clear cell renal cell carcinoma Cancer Genome Atlas Research Network Analysis working group: Baylor College ... Nature 499 (7456), 43-49, 2013 | 3619* | 2013 |
mTOR inhibition induces upstream receptor tyrosine kinase signaling and activates Akt KE O'Reilly, F Rojo, QB She, D Solit, GB Mills, D Smith, H Lane, ... Cancer research 66 (3), 1500-1508, 2006 | 2988 | 2006 |
Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas Cancer Genome Atlas Research Network New England Journal of Medicine 372 (26), 2481-2498, 2015 | 2922 | 2015 |
Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2693 | 2015 |
An integrated TCGA pan-cancer clinical data resource to drive high-quality survival outcome analytics J Liu, T Lichtenberg, KA Hoadley, LM Poisson, AJ Lazar, AD Cherniack, ... Cell 173 (2), 400-416. e11, 2018 | 2647 | 2018 |
The molecular taxonomy of primary prostate cancer A Abeshouse, J Ahn, R Akbani, A Ally, S Amin, CD Andry, M Annala, ... Cell 163 (4), 1011-1025, 2015 | 2623 | 2015 |
Comprehensive molecular characterization of urothelial bladder carcinoma Cancer Genome Atlas Research Network Nature 507 (7492), 315, 2014 | 2622 | 2014 |
Exploiting the PI3K/AKT pathway for cancer drug discovery BT Hennessy, DL Smith, PT Ram, Y Lu, GB Mills Nature reviews Drug discovery 4 (12), 988-1004, 2005 | 2596 | 2005 |
Integrated genomic characterization of papillary thyroid carcinoma N Agrawal, R Akbani, BA Aksoy, A Ally, H Arachchi, SL Asa, JT Auman, ... Cell 159 (3), 676-690, 2014 | 2530 | 2014 |
Oncogenic signaling pathways in the cancer genome atlas F Sanchez-Vega, M Mina, J Armenia, WK Chatila, A Luna, KC La, ... Cell 173 (2), 321-337. e10, 2018 | 2496 | 2018 |